🧬 Computational Analysis of Post-Translational Modifications in Diabetes: A Systems Biology and Structure-Based Drug Discovery ApproachAn advanced bioinformatics and computational biology project focused on investigating the role of post-translational modifications (PTMs) in diabetes progression and identifying potential therapeutic targets using systems biology and structure-based drug discovery approaches.Diabetes is a complex metabolic disorder associated with dysregulation of multiple cellular signaling pathways, protein functions, and metabolic networks. Post-translational modifications such as phosphorylation, glycosylation, acetylation, ubiquitination, and methylation play critical roles in regulating protein activity, insulin signaling, glucose metabolism, inflammatory responses, and cellular homeostasis. Abnormal PTM patterns are strongly linked to insulin resistance, β-cell dysfunction, oxidative stress, and diabetic complications.This project aimed to computationally analyze diabetes-associated proteins and investigate how specific PTMs influence protein structure, stability, molecular interactions, and disease-related pathways. The study integrated systems biology analysis with structural bioinformatics and molecular modeling techniques to better understand the molecular mechanisms underlying diabetes progression and identify promising druggable targets.The workflow included large-scale protein network analysis, pathway enrichment, structural modeling, molecular docking, and interaction profiling to evaluate potential therapeutic compounds capable of modulating PTM-regulated targets involved in diabetic pathways.🔬 Project Objectives:
• Analyze the impact of post-translational modifications on diabetes-related proteins
• Identify key PTMs associated with insulin signaling dysfunction and metabolic imbalance
• Explore protein interaction networks and disease-associated pathways
• Investigate structural and functional alterations caused by PTMs
• Identify potential therapeutic targets through computational drug discovery approaches
• Evaluate candidate compounds using structure-based molecular docking analysis🧪 Computational Workflow:
• Retrieval and curation of diabetes-associated proteins and PTM datasets
• Protein sequence and structural analysis
• PTM site prediction and functional annotation
• Protein-protein interaction network construction
• Systems biology and pathway enrichment analysis
• Molecular docking simulations against target proteins
• Binding affinity and interaction stability analysis
• Structural visualization and comparative analysis
• Candidate therapeutic screening and target prioritization💻 Techniques & Bioinformatics Approaches:
• Systems Biology Analysis
• Structural Bioinformatics
• Molecular Docking
• Protein Modeling
• PTM Prediction & Annotation
• Network Biology
• Computational Drug Discovery
• Pathway Enrichment Analysis
• Molecular Interaction Analysis
• In Silico Therapeutic Screening📊 Research Significance:
This project highlights the critical role of post-translational modifications in diabetes pathogenesis and demonstrates how computational biology can accelerate the identification of novel therapeutic strategies. By integrating systems biology with structure-based drug discovery, the study provides deeper molecular insights into diabetes progression and supports the development of more precise and targeted treatment approaches. A multidisciplinary computational study combining bioinformatics, systems biology, and molecular modeling to uncover innovative therapeutic opportunities in diabetes research.